Oncogenes and Growth Factor Receptors As Diagnostic and Prognostic Markers in Precancers and Cancers of the Oral Mucosa

作者: A. Burkhardt

DOI: 10.1007/978-3-642-80169-3_8

关键词:

摘要: Cancer, if not in essence a genetic disease, is at least to large extent determined its behaviour by the interaction of number genetically coded products, which may enhance growth (oncogenes) or suppress it (tumour suppressor genes anti-oncogenes). However, changes various cancers show considerable individual variations some maybe geographic aetiological factors. Overall, 50%–96% oral carcinomas have abnormal karyotypes (Owen et al. 1992; Hittelman 1993), and there high frequency breakpoints deletions Patel 1993; Partridge 1994; Fuzesi 1994). All chromosomes be involved, noteworthy that those encoding well-known oncogenes (or tumour genes) are frequently altered, such as chromosome 1, 3, 7 (epidermal factor receptor, EGFR), 8 (myc), 9 (MTS), 11 (ras, bcll, intl), 13 (erb), 17 (neu, p53) 18 (Patel Voravud Tsuji Details outlined chapter Scholes Field this volume.

参考文章(122)
Chris W Dawson, Aristides G Eliopoulos, Dawson J, Lawrence S Young, None, BHRF1, a viral homologue of the Bcl-2 oncogene, disturbs epithelial cell differentiation. Oncogene. ,vol. 10, pp. 69- 77 ,(1995)
H. M. Cherrick, Sheng-Lin Li, No-Hee Park, C. N. Bertolami, Myong Soo Kim, State of p53, Rb and DCC tumor suppressor genes in human oral cancer cell lines. Anticancer Research. ,vol. 13, pp. 1405- 1413 ,(1993)
Narin Voravud, Dong M Shin, Jae Y Ro, Jin S Lee, Waun Ki Hong, Walter N Hittelman, None, Increased Polysomies of Chromosomes 7 and 17 during Head and Neck Multistage Tumorigenesis Cancer Research. ,vol. 53, pp. 2874- 2883 ,(1993)
W J Gullick, P Kelly, Sainsbury, C Wright, A L Harris, B Angus, J Cairns, S Nicholson, C H Horne, Expression of c-erbB-2 Oncoprotein: A Prognostic Indicator in Human Breast Cancer Cancer Research. ,vol. 49, pp. 2087- 2090 ,(1989)
S. Cohen, H. Ushiro, C. Stoscheck, M. Chinkers, A native 170,000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles. Journal of Biological Chemistry. ,vol. 257, pp. 1523- 1531 ,(1982) , 10.1016/S0021-9258(19)68224-4
Vincent F. Vellucci, Zhao-ling Zhou, Ellen B. Stash, Michael Reiss, Activation of the Autocrine Transforming Growth Factor α Pathway in Human Squamous Carcinoma Cells Cancer Research. ,vol. 51, pp. 6254- 6262 ,(1991)
S Paik, R Hazan, E R Fisher, R E Sass, B Fisher, C Redmond, J Schlessinger, M E Lippman, C R King, Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer. Journal of Clinical Oncology. ,vol. 8, pp. 103- 112 ,(1990) , 10.1200/JCO.1990.8.1.103
Jordan Gutterman, Mark Blick, Jin S. Lee, Peter G. Sacks, Avraham Eisbruch, Analysis of the Epidermal Growth Factor Receptor Gene in Fresh Human Head and Neck Tumors Cancer Research. ,vol. 47, pp. 3603- 3605 ,(1987)
S Toikkanen, H Helin, J Isola, H Joensuu, Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up. Journal of Clinical Oncology. ,vol. 10, pp. 1044- 1048 ,(1992) , 10.1200/JCO.1992.10.7.1044
Fred J. Hendler, Brian L. Hawkins, Bo Yuan, Douglas M. Ackermann, Briana W. Heniford, Harvey ras (H-ras) Point Mutations Are Induced by 4-Nitroquinoline-1-oxide in Murine Oral Squamous Epithelia, while Squamous Cell Carcinomas and Loss of Heterozygosity Occur without Additional Exposure Cancer Research. ,vol. 54, pp. 5310- 5317 ,(1994)